Uruguay

Uruguay

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.27 (0.23 - 0.32) 2019 Modelled IHME
0.29 (0.24 - 0.33) 2018 Modelled IHME
0.29 (0.25 - 0.34) 2017 Modelled IHME
0.3 (0.25 - 0.34) 2016 Modelled IHME
0.3 (0.24 - 0.34) 2015 Modelled IHME
0.3 (0.25 - 0.34) 2014 Modelled IHME
0.3 (0.25 - 0.34) 2013 Modelled IHME
0.3 (0.25 - 0.35) 2012 Modelled IHME
0.3 (0.25 - 0.35) 2011 Modelled IHME
0.31 (0.25 - 0.36) 2010 Modelled IHME
0.31 (0.26 - 0.36) 2009 Modelled IHME
0.31 (0.26 - 0.37) 2008 Modelled IHME
0.32 (0.27 - 0.37) 2007 Modelled IHME
0.32 (0.27 - 0.37) 2006 Modelled IHME
0.33 (0.28 - 0.38) 2005 Modelled IHME
0.33 (0.28 - 0.39) 2004 Modelled IHME
0.34 (0.28 - 0.39) 2003 Modelled IHME
0.34 (0.29 - 0.40) 2002 Modelled IHME
0.34 (0.29 - 0.40) 2001 Modelled IHME
0.35 (0.29 - 0.41) 2000 Modelled IHME
0.35 (0.29 - 0.40) 1999 Modelled IHME
0.35 (0.29 - 0.41) 1998 Modelled IHME
0.35 (0.29 - 0.41) 1997 Modelled IHME
0.35 (0.29 - 0.41) 1996 Modelled IHME
0.35 (0.29 - 0.41) 1995 Modelled IHME
0.35 (0.29 - 0.41) 1994 Modelled IHME
0.35 (0.29 - 0.41) 1993 Modelled IHME
0.35 (0.29 - 0.42) 1992 Modelled IHME
0.35 (0.29 - 0.42) 1991 Modelled IHME
0.35 (0.29 - 0.42) 1990 Modelled IHME
1.04 (0.10 - 8.59) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0.01 - 0.02) 2019 Modelled IHME
0.01 (0.01 - 0.02) 2018 Modelled IHME
0.02 (0.01 - 0.02) 2017 Modelled IHME
0.02 (0.01 - 0.02) 2016 Modelled IHME
0.02 (0.01 - 0.02) 2015 Modelled IHME
0.02 (0.01 - 0.02) 2014 Modelled IHME
0.02 (0.01 - 0.02) 2013 Modelled IHME
0.02 (0.01 - 0.02) 2012 Modelled IHME
0.01 (0.01 - 0.02) 2011 Modelled IHME
0.01 (0.01 - 0.02) 2010 Modelled IHME
0.01 (0.01 - 0.02) 2009 Modelled IHME
0.02 (0.01 - 0.02) 2008 Modelled IHME
0.02 (0.01 - 0.02) 2007 Modelled IHME
0.02 (0.01 - 0.02) 2006 Modelled IHME
0.02 (0.01 - 0.02) 2005 Modelled IHME
0.02 (0.01 - 0.02) 2004 Modelled IHME
0.02 (0.01 - 0.02) 2003 Modelled IHME
0.02 (0.01 - 0.02) 2002 Modelled IHME
0.02 (0.01 - 0.02) 2001 Modelled IHME
0.02 (0.01 - 0.03) 2000 Modelled IHME
0.03 (0.02 - 0.04) 1999 Modelled IHME
0.06 (0.04 - 0.08) 1998 Modelled IHME
0.09 (0.06 - 0.12) 1997 Modelled IHME
0.12 (0.08 - 0.16) 1996 Modelled IHME
0.13 (0.09 - 0.18) 1995 Modelled IHME
0.13 (0.09 - 0.18) 1994 Modelled IHME
0.13 (0.09 - 0.18) 1993 Modelled IHME
0.13 (0.09 - 0.18) 1992 Modelled IHME
0.13 (0.08 - 0.19) 1991 Modelled IHME
0.13 (0.08 - 0.19) 1990 Modelled IHME
0.35 (0.03 - 3.20) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
11,107 (8,950 - 13,336) 1990 Modelled IHME
11,142 (9,071 - 13,198) 1991 Modelled IHME
11,177 (9,195 - 13,200) 1992 Modelled IHME
11,210 (9,286 - 13,227) 1993 Modelled IHME
11,245 (9,300 - 13,224) 1994 Modelled IHME
11,281 (9,375 - 13,376) 1995 Modelled IHME
11,319 (9,437 - 13,302) 1996 Modelled IHME
11,353 (9,502 - 13,271) 1997 Modelled IHME
11,379 (9,588 - 13,296) 1998 Modelled IHME
11,391 (9,591 - 13,287) 1999 Modelled IHME
11,390 (9,598 - 13,385) 2000 Modelled IHME
11,358 (9,612 - 13,226) 2001 Modelled IHME
11,286 (9,557 - 13,188) 2002 Modelled IHME
11,186 (9,422 - 13,022) 2003 Modelled IHME
11,073 (9,321 - 12,864) 2004 Modelled IHME
10,964 (9,161 - 12,658) 2005 Modelled IHME
10,842 (9,117 - 12,475) 2006 Modelled IHME
10,696 (8,966 - 12,349) 2007 Modelled IHME
10,547 (8,809 - 12,224) 2008 Modelled IHME
10,416 (8,711 - 12,185) 2009 Modelled IHME
10,322 (8,574 - 12,174) 2010 Modelled IHME
10,254 (8,517 - 11,927) 2011 Modelled IHME
10,191 (8,457 - 11,810) 2012 Modelled IHME
10,139 (8,391 - 11,673) 2013 Modelled IHME
10,101 (8,329 - 11,642) 2014 Modelled IHME
10,081 (8,272 - 11,650) 2015 Modelled IHME
10,081 (8,412 - 11,644) 2016 Modelled IHME
10,069 (8,463 - 11,726) 2017 Modelled IHME
9,855 (8,381 - 11,388) 2018 Modelled IHME
9,413 (7,863 - 10,916) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.87 (1.42 - 2.41) 2019 Modelled IHME
1.85 (1.42 - 2.38) 2018 Modelled IHME
1.84 (1.40 - 2.36) 2017 Modelled IHME
1.82 (1.39 - 2.32) 2016 Modelled IHME
1.83 (1.40 - 2.33) 2015 Modelled IHME
1.82 (1.39 - 2.33) 2014 Modelled IHME
1.83 (1.40 - 2.34) 2013 Modelled IHME
1.85 (1.42 - 2.38) 2012 Modelled IHME
1.84 (1.40 - 2.36) 2011 Modelled IHME
1.8 (1.37 - 2.31) 2010 Modelled IHME
1.89 (1.43 - 2.43) 2009 Modelled IHME
2.16 (1.63 - 2.81) 2008 Modelled IHME
2.52 (1.92 - 3.29) 2007 Modelled IHME
2.69 (2.03 - 3.48) 2006 Modelled IHME
2.82 (2.12 - 3.68) 2005 Modelled IHME
2.83 (2.13 - 3.70) 2004 Modelled IHME
2.84 (2.11 - 3.72) 2003 Modelled IHME
2.84 (2.10 - 3.71) 2002 Modelled IHME
2.88 (2.12 - 3.75) 2001 Modelled IHME
2.94 (2.17 - 3.85) 2000 Modelled IHME
3.02 (2.20 - 3.96) 1999 Modelled IHME
3.04 (2.22 - 3.99) 1998 Modelled IHME
3.04 (2.21 - 3.97) 1997 Modelled IHME
3.09 (2.25 - 4) 1996 Modelled IHME
3.14 (2.30 - 4.08) 1995 Modelled IHME
3.16 (2.31 - 4.12) 1994 Modelled IHME
3.16 (2.31 - 4.12) 1993 Modelled IHME
3.12 (2.27 - 4.11) 1992 Modelled IHME
3.1 (2.25 - 4.08) 1991 Modelled IHME
3.01 (2.20 - 3.97) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
64 (49 - 83) 2019 Modelled IHME
64 (49 - 82) 2018 Modelled IHME
63 (48 - 81) 2017 Modelled IHME
62 (47 - 79) 2016 Modelled IHME
62 (48 - 79) 2015 Modelled IHME
62 (47 - 79) 2014 Modelled IHME
62 (47 - 79) 2013 Modelled IHME
63 (48 - 80) 2012 Modelled IHME
62 (47 - 80) 2011 Modelled IHME
61 (46 - 78) 2010 Modelled IHME
63 (48 - 82) 2009 Modelled IHME
72 (55 - 94) 2008 Modelled IHME
84 (64 - 110) 2007 Modelled IHME
90 (68 - 116) 2006 Modelled IHME
94 (71 - 122) 2005 Modelled IHME
94 (71 - 123) 2004 Modelled IHME
94 (70 - 123) 2003 Modelled IHME
94 (70 - 123) 2002 Modelled IHME
95 (70 - 124) 2001 Modelled IHME
97 (71 - 127) 2000 Modelled IHME
99 (72 - 130) 1999 Modelled IHME
100 (73 - 131) 1998 Modelled IHME
99 (72 - 130) 1997 Modelled IHME
100 (73 - 130) 1996 Modelled IHME
102 (74 - 132) 1995 Modelled IHME
102 (74 - 132) 1994 Modelled IHME
101 (74 - 132) 1993 Modelled IHME
99 (72 - 131) 1992 Modelled IHME
98 (71 - 129) 1991 Modelled IHME
94 (69 - 125) 1990 Modelled IHME
92 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
17 (11 - 23) 2019 Modelled IHME
17 (11 - 23) 2018 Modelled IHME
17 (12 - 23) 2017 Modelled IHME
16 (12 - 23) 2016 Modelled IHME
17 (12 - 23) 2015 Modelled IHME
17 (12 - 24) 2014 Modelled IHME
17 (12 - 24) 2013 Modelled IHME
17 (12 - 24) 2012 Modelled IHME
17 (12 - 24) 2011 Modelled IHME
17 (12 - 25) 2010 Modelled IHME
17 (12 - 25) 2009 Modelled IHME
18 (12 - 25) 2008 Modelled IHME
18 (13 - 26) 2007 Modelled IHME
19 (13 - 26) 2006 Modelled IHME
19 (13 - 26) 2005 Modelled IHME
19 (13 - 26) 2004 Modelled IHME
19 (13 - 26) 2003 Modelled IHME
19 (13 - 26) 2002 Modelled IHME
19 (13 - 26) 2001 Modelled IHME
19 (13 - 26) 2000 Modelled IHME
19 (13 - 26) 1999 Modelled IHME
19 (13 - 26) 1998 Modelled IHME
19 (13 - 27) 1997 Modelled IHME
19 (13 - 27) 1996 Modelled IHME
19 (13 - 27) 1995 Modelled IHME
19 (13 - 27) 1994 Modelled IHME
19 (13 - 27) 1993 Modelled IHME
19 (13 - 27) 1992 Modelled IHME
19 (13 - 27) 1991 Modelled IHME
19 (13 - 27) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2018 Survey/reported WHO/UNICEF
93 2017 Survey/reported WHO/UNICEF
95 2016 Survey/reported WHO/UNICEF
95 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
94 2013 Survey/reported WHO/UNICEF
95 2012 Survey/reported WHO/UNICEF
95 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
95 2009 Survey/reported WHO/UNICEF
94 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
95 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
94 2004 Survey/reported WHO/UNICEF
91 2003 Survey/reported WHO/UNICEF
95 2002 Survey/reported WHO/UNICEF
94 2001 Survey/reported WHO/UNICEF
92 2000 Survey/reported WHO/UNICEF
93 1999 Survey/reported WHO/UNICEF
94 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.5 (0.41 - 0.61) 2019 Modelled IHME
0.5 (0.41 - 0.61) 2018 Modelled IHME
0.49 (0.41 - 0.60) 2017 Modelled IHME
0.49 (0.40 - 0.59) 2016 Modelled IHME
0.49 (0.39 - 0.59) 2015 Modelled IHME
0.48 (0.39 - 0.59) 2014 Modelled IHME
0.48 (0.39 - 0.58) 2013 Modelled IHME
0.47 (0.39 - 0.57) 2012 Modelled IHME
0.47 (0.38 - 0.57) 2011 Modelled IHME
0.47 (0.38 - 0.57) 2010 Modelled IHME
0.47 (0.38 - 0.57) 2009 Modelled IHME
0.46 (0.38 - 0.56) 2008 Modelled IHME
0.46 (0.38 - 0.56) 2007 Modelled IHME
0.46 (0.37 - 0.56) 2006 Modelled IHME
0.46 (0.37 - 0.56) 2005 Modelled IHME
0.46 (0.37 - 0.55) 2004 Modelled IHME
0.46 (0.37 - 0.55) 2003 Modelled IHME
0.46 (0.37 - 0.55) 2002 Modelled IHME
0.45 (0.37 - 0.55) 2001 Modelled IHME
0.45 (0.37 - 0.55) 2000 Modelled IHME
0.46 (0.37 - 0.55) 1999 Modelled IHME
0.46 (0.37 - 0.55) 1998 Modelled IHME
0.46 (0.37 - 0.56) 1997 Modelled IHME
0.46 (0.38 - 0.56) 1996 Modelled IHME
0.46 (0.38 - 0.56) 1995 Modelled IHME
0.46 (0.38 - 0.56) 1994 Modelled IHME
0.46 (0.38 - 0.56) 1993 Modelled IHME
0.46 (0.38 - 0.56) 1992 Modelled IHME
0.46 (0.38 - 0.56) 1991 Modelled IHME
0.46 (0.38 - 0.56) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
21.9 (19 - 24.80) 2003 Survey/reported Osimani ML and Guchin M, 2004
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
14,496 (11,781 - 17,735) 1990 Modelled IHME
14,587 (11,909 - 17,809) 1991 Modelled IHME
14,672 (11,969 - 17,956) 1992 Modelled IHME
14,750 (12,061 - 18,007) 1993 Modelled IHME
14,824 (12,151 - 18,152) 1994 Modelled IHME
14,895 (12,205 - 18,261) 1995 Modelled IHME
14,945 (12,266 - 18,283) 1996 Modelled IHME
14,966 (12,233 - 18,241) 1997 Modelled IHME
14,970 (12,213 - 18,155) 1998 Modelled IHME
14,974 (12,209 - 18,074) 1999 Modelled IHME
14,996 (12,152 - 18,147) 2000 Modelled IHME
15,040 (12,210 - 18,133) 2001 Modelled IHME
15,089 (12,282 - 18,165) 2002 Modelled IHME
15,141 (12,348 - 18,286) 2003 Modelled IHME
15,195 (12,357 - 18,450) 2004 Modelled IHME
15,251 (12,314 - 18,647) 2005 Modelled IHME
15,321 (12,434 - 18,685) 2006 Modelled IHME
15,412 (12,586 - 18,674) 2007 Modelled IHME
15,520 (12,654 - 18,817) 2008 Modelled IHME
15,642 (12,756 - 19,025) 2009 Modelled IHME
15,769 (12,805 - 19,187) 2010 Modelled IHME
15,901 (12,957 - 19,215) 2011 Modelled IHME
16,046 (13,088 - 19,366) 2012 Modelled IHME
16,203 (13,234 - 19,701) 2013 Modelled IHME
16,371 (13,311 - 19,897) 2014 Modelled IHME
16,544 (13,345 - 20,104) 2015 Modelled IHME
16,750 (13,678 - 20,274) 2016 Modelled IHME
16,931 (13,890 - 20,598) 2017 Modelled IHME
17,048 (13,988 - 20,839) 2018 Modelled IHME
17,138 (13,970 - 20,858) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
6.4 (5.15 - 7.84) 2019 Modelled IHME
6.33 (5.08 - 7.76) 2018 Modelled IHME
6.28 (5.06 - 7.66) 2017 Modelled IHME
6.2 (5 - 7.54) 2016 Modelled IHME
6.22 (5 - 7.50) 2015 Modelled IHME
6.19 (4.97 - 7.50) 2014 Modelled IHME
6.24 (4.98 - 7.61) 2013 Modelled IHME
6.36 (5.11 - 7.78) 2012 Modelled IHME
6.3 (5.07 - 7.67) 2011 Modelled IHME
6.13 (4.94 - 7.52) 2010 Modelled IHME
6.08 (4.93 - 7.48) 2009 Modelled IHME
6.06 (4.86 - 7.39) 2008 Modelled IHME
6.14 (4.95 - 7.50) 2007 Modelled IHME
5.85 (4.68 - 7.15) 2006 Modelled IHME
5.89 (4.73 - 7.22) 2005 Modelled IHME
5.94 (4.77 - 7.30) 2004 Modelled IHME
6 (4.80 - 7.40) 2003 Modelled IHME
6.05 (4.83 - 7.46) 2002 Modelled IHME
6.16 (4.88 - 7.62) 2001 Modelled IHME
6.28 (4.95 - 7.74) 2000 Modelled IHME
6.47 (5.11 - 7.99) 1999 Modelled IHME
6.49 (5.12 - 8.04) 1998 Modelled IHME
6.47 (5.08 - 8) 1997 Modelled IHME
6.52 (5.09 - 8.10) 1996 Modelled IHME
6.63 (5.15 - 8.27) 1995 Modelled IHME
6.67 (5.21 - 8.31) 1994 Modelled IHME
6.69 (5.24 - 8.33) 1993 Modelled IHME
6.65 (5.21 - 8.30) 1992 Modelled IHME
6.69 (5.26 - 8.32) 1991 Modelled IHME
6.51 (5.12 - 8.09) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
220 (177 - 269) 2019 Modelled IHME
217 (174 - 266) 2018 Modelled IHME
215 (173 - 262) 2017 Modelled IHME
212 (171 - 257) 2016 Modelled IHME
212 (170 - 255) 2015 Modelled IHME
210 (169 - 255) 2014 Modelled IHME
212 (169 - 258) 2013 Modelled IHME
215 (173 - 263) 2012 Modelled IHME
213 (171 - 259) 2011 Modelled IHME
206 (166 - 253) 2010 Modelled IHME
204 (165 - 251) 2009 Modelled IHME
203 (163 - 247) 2008 Modelled IHME
205 (165 - 251) 2007 Modelled IHME
195 (156 - 238) 2006 Modelled IHME
196 (157 - 240) 2005 Modelled IHME
197 (158 - 243) 2004 Modelled IHME
199 (159 - 246) 2003 Modelled IHME
200 (160 - 247) 2002 Modelled IHME
204 (161 - 252) 2001 Modelled IHME
207 (163 - 255) 2000 Modelled IHME
213 (168 - 263) 1999 Modelled IHME
213 (168 - 263) 1998 Modelled IHME
211 (166 - 261) 1997 Modelled IHME
212 (165 - 263) 1996 Modelled IHME
214 (167 - 267) 1995 Modelled IHME
214 (167 - 267) 1994 Modelled IHME
214 (168 - 266) 1993 Modelled IHME
211 (166 - 264) 1992 Modelled IHME
211 (166 - 263) 1991 Modelled IHME
204 (161 - 254) 1990 Modelled IHME
98 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
38 (29 - 47) 2019 Modelled IHME
38 (29 - 47) 2018 Modelled IHME
38 (29 - 47) 2017 Modelled IHME
38 (29 - 47) 2016 Modelled IHME
38 (29 - 47) 2015 Modelled IHME
38 (28 - 47) 2014 Modelled IHME
38 (28 - 47) 2013 Modelled IHME
38 (28 - 47) 2012 Modelled IHME
38 (28 - 47) 2011 Modelled IHME
37 (28 - 47) 2010 Modelled IHME
38 (28 - 47) 2009 Modelled IHME
37 (28 - 47) 2008 Modelled IHME
37 (28 - 47) 2007 Modelled IHME
37 (28 - 47) 2006 Modelled IHME
37 (27 - 47) 2005 Modelled IHME
37 (27 - 47) 2004 Modelled IHME
37 (27 - 47) 2003 Modelled IHME
37 (28 - 47) 2002 Modelled IHME
37 (27 - 47) 2001 Modelled IHME
37 (27 - 47) 2000 Modelled IHME
37 (28 - 47) 1999 Modelled IHME
37 (28 - 47) 1998 Modelled IHME
37 (28 - 47) 1997 Modelled IHME
37 (27 - 47) 1996 Modelled IHME
37 (27 - 46) 1995 Modelled IHME
37 (27 - 46) 1994 Modelled IHME
37 (27 - 46) 1993 Modelled IHME
37 (27 - 46) 1992 Modelled IHME
37 (28 - 47) 1991 Modelled IHME
37 (27 - 47) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.27 (%)
2019
(0.23 - 0.32(%))
IHME
HCV (RNA/cAg+)
0.5 (%)
2019
(0.41 - 0.61(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
64
2019
(49 - 83)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
220
2019
(177 - 269)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.01 (%)
2019, latest modelled
(0.01 - 0.02(%))
IHME

Prevalence PWID

HCV
21.90 (%)
2003, survey/surveillance
(19 - 24.80(%))
Osimani ML and Guchin M, 2004

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources